Influence of Beta-Endorphin on Oxygen Activity of Neutrophils and Total Antioxidant Status in Rats after Chronic Administration of Methimazole

1. Bartosz G.: Second face of oxygen. Edited by PWN, Warszawa, 2004.Search in Google Scholar

2. Bhargava H.N., Ramarao P., Gulati A.: Effect of methimazole-induced hypothyroidism on multiple opioid receptors in rat brain regions. Pharmacology 1988, 37, 356-364.10.1159/000138489Search in Google Scholar

3. Blumberg P.M.: Protein kinase C as the receptor for phorbol esters tumor promoters. Cancer Res 1988, 48, 1−8.Search in Google Scholar

4. Cano-Europa E., Blas-Valdivia V., Lopez-Galindo G.E., Franco-Colin M., Pineda-Reynoso M., Hernandez-Garcia A., Ortiz-Butron R.: Methimazole-induced hypothyroidism causes alteration of the REDOX environment, oxidative stress, and hepatic damage; events not caused by hypothyroidism itself. Ann Hepatol 2010, 9, 80-88.Search in Google Scholar

5. Cheng M.C., Smith A.I., Funder J.W.: Beta-endorphin and its congeners in rat pituitary and thyroid: effects of propylthiouracil and thyroid hormone administration. Endocrinology 1986, 119, 642-647.10.1210/endo-119-2-642Search in Google Scholar

6. Cooper D.S.: Antithyroid drugs for the treatment of hyperthyroidism caused by Graves’ disease. Endocrinol Metab Clin North Am 1998, 27, 225-247.10.1016/S0889-8529(05)70308-XSearch in Google Scholar

7. Das K., Chainy G.B.N.: Modulation of rat liver mitochondrial antioxidant defence system by thyroid hormone. Biochim Biophys Acta 2001, 1537, 1-13.10.1016/S0925-4439(01)00048-5Search in Google Scholar

8. Das K., Chainy G.B.N.: Thyroid hormone influences antioxidant defense system in adult rat brain. Neurochem Res 2004, 29, 1755-1766.10.1023/B:NERE.0000035812.58200.a9Search in Google Scholar

9. Dröge W.: Free radicals in the physiological control of cell function. Physiol Rev 2002, 82, 47-95.10.1152/physrev.00018.2001Search in Google Scholar

10. Ferreira A.C., de Carvalho Cardoso L., Rosenthal D., de Carvalho D.P.: Thyroid Ca2+/NADPH-dependent H2O2 generation is partially inhibited by propylthiouracil and methimazole. Eur J Biochem 2003, 270, 2363-2368.10.1046/j.1432-1033.2003.03576.xSearch in Google Scholar

11. Glatstein M.M., Garcia-Bournissen F., Giglio N., Finkelstein Y., Koren G.: Pharmacologic treatment of hyperthyroidism during lactation. Can Fam Physician 2009, 55, 797-798.Search in Google Scholar

12. Hill K.E., Gieseg M.A., Kingsbury D., Lopez-Villalobos N., Bridges J., Chambers P.: The efficacy and safety of a novel lipophilic formulation of methimazole for the once daily transdermal treatment of cats with hyperthyroidism. J Vet Intern Med 2011, 25, 1357-1365.10.1111/j.1939-1676.2011.00799.xSearch in Google Scholar

13. Hoffmann G., Marks S.L., Taboada J., Hosgood G.L., Wolfsheimer K.J.: Transdermal methimazole treatment in cats with hyperthyroidism. J Feline Med Surg 2003, 5, 77-82.10.1016/S1098-612X(02)00095-5Search in Google Scholar

14. Hulbert A.J.: Thyroid hormones and their effects: a new perspective. Biol Rev Cambridge Philos Soc 2000, 75, 519-621.10.1017/S146479310000556XSearch in Google Scholar

15. Humar M., Dohrmann H., Stein P., Andriopoulos N., Goebel U., Roesslein M.: Thionamides inhibit the transcription factor nuclear factor-kappaB by suppression of Rac1 and inhibitor of kappaB kinase alpha. J Pharmacol Exp Ther 2008, 324, 1037-1044.10.1124/jpet.107.132407Search in Google Scholar

16. Ís¸man Ç.A., Yeg˘en B.Ç., Alican Í.: Methimazoleinduced hypothyroidism in rats ameliorates oxidative injury in experimental colitis. J Endocrinol 2003, 177, 471-476.10.1677/joe.0.1770471Search in Google Scholar

17. Jakóbisiak M. Immunology. Edited by PWN, Warszawa, 1995.Search in Google Scholar

18. Lécuyer M., Prini S., Dunn M.E., Doucet M.Y.: Clinical efficacy and safety of transdermal methimazole in the treatment of feline hyperthyroidism. Can Vet J 2006, 47, 131-135.Search in Google Scholar

19. Marlin D.J., Fenn K., Smith N., Deaton C.D., Roberts C.A., Harris P.A., Dunster C., Kelly F.J.: Changes in circulatory antioxidant status in horses during prolonged exercise. J Nutr 2002, 132, 1622-1627.10.1093/jn/132.6.1622SSearch in Google Scholar

20. Meier C.A., Fabbro D., Meyhack I., Hemmings B., Olbrecht U., Jakob A., Walter P.: Effect of hypothyroidism and thyroid hormone replacement on the level of protein kinase C and protein kinase A in rat liver. FEBS Lett 1991, 6, 397-400.10.1016/0014-5793(91)80522-5Search in Google Scholar

21. Menzebach A., Hirsch J., Hempelmann G., Welters I.D.: Effects of endogenous and synthetic opioid peptides on neutrophil function in vitro. Brit J Anaesth 2003, 91, 546-550.10.1093/bja/aeg219Search in Google Scholar

22. Nishiki K., Ericinska M., Wilson D.F., Cooper S.: Evaluation of oxidative phosphorylation in hearts from euthyroid, hypothyroid and hyperthyroid rats. Am J Physiol 1978, 235, 212-219.10.1152/ajpcell.1978.235.5.C212Search in Google Scholar

23. Paller M.S.: Hypothyroidism protects against free radical damage in ischemic acute renal failure. Kidn Int 1986, 29, 1162-1166.10.1038/ki.1986.122Search in Google Scholar

24. Peterson M.E., Aucoin D.P.: Comparison of the disposition of carbimazole and methimazole in clinically normal cats. Res Vet Sci 1993, 54, 351-355.10.1016/0034-5288(93)90134-2Search in Google Scholar

25. Peterson M.E., Kintzer P.P., Hurvitz A.I.: Methimazole treatment of 262 cats with hyperthyroidism. J Vet Intern Med 1988, 2, 150-157.10.1111/j.1939-1676.1988.tb02812.x3265728Search in Google Scholar

26. Petrulea M.S., Duncea I., Hazi G., Dragotoiu G., Decea N., Mureşan A.: Oxidative stress in experimental hypothyroidism: effect of vitamin E supplementation. Clujul Medical 2010, 84, 245-249.Search in Google Scholar

27. Regelmann M.O., Miloh T., Arnon R., Morotti R., Kerkar N., Rapaport R.: Graves disease presenting with severe cholestasis. Thyroid 2012, 22, 437-439.10.1089/thy.2011.026722458973Search in Google Scholar

28. Rook G.A.W., Steele J., Umar S., Deckrell H.M.: A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by interferon. J Immun Methods 1985, 82, 161-167.10.1016/0022-1759(85)90235-2Search in Google Scholar

29. Rosen H., Klebanoff S.J.: Formation of singlet oxygen by the myeloperoxidase-mediated antimicrobial system. J Biol Chem 1977, 25, 4803-4810.10.1016/S0021-9258(17)40127-XSearch in Google Scholar

30. Sarandöl E., Tas S., Dirican M., Serdar Z.: Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation. Cell Biochem Funct 2005, 23, 1-8.10.1002/cbf.1119Search in Google Scholar

31. Schlaifer D., Cooper M.R., Attal M., Rousseau A., Pris J., Laurent G., Myers C.E.: Potential strategies for circumventing myeloperoxidase-catalyzed degradation of vinca alkaloids. Leukemia 1994, 8, 668-671.Search in Google Scholar

32. Sewerynek J., Wiktorska J., Nowak D., Lewinski A.: Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease. Endocr Regul 2000, 34, 83-89.Search in Google Scholar

33. Sharp B.M., Keane W.F., Suh H.J., Gekker G., Tsukayama D., Peterson P.K.: Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology 1985, 117, 793-795.10.1210/endo-117-2-793Search in Google Scholar

34. Sulowska Z., Majewska E., Krawczyk K., Klink M., Tchórzewski H.: Influence of opioid peptides on human neutrophil apoptosis and activation in vitro. Mediat Inflamm 2002, 4, 245-250.10.1080/096293502900000104Search in Google Scholar

35. Swaroo A., Ramasarma T.: Heat exposure and hypothyroid conditions decrease hydrogen peroxide generation in liver mitochondria. Bioch J 1985, 226, 403-408.10.1042/bj2260403Search in Google Scholar

36. Trepanier L.A.: Pharmacologic management of feline hyperthyroidism. Vet Clin North Am Small Anim Pract 2007, 37, 775-788.10.1016/j.cvsm.2007.03.004Search in Google Scholar

37. Vail D.M., Elfarra A.A., Panciera D.L., Hutson P.R.: Pharmacokinetics and short-term clinicopathologic changes after intravenous administration of a high dose of methimazole in dogs. Am J Vet Res 1994, 55, 1597-1601.Search in Google Scholar

38. Weetman A.P., Holt M.E., Campbell A.K., Hall R., Mc- Gregor A.M.: Methimazole and generation of oxygen radicals by monocytes: Potential role in immunosuppression. Br Med J 1984, 288, 518-520.10.1136/bmj.288.6416.518Search in Google Scholar

39. Yang M., Qu H., Deng H.C.: Acute pancreatitis induced by methimazole in a patient with Graves' disease. Thyroid 2012, 22, 94-96.10.1089/thy.2011.0210Search in Google Scholar

40. Ziegler D.M.: Flavin-containing monooxygenases: enzymes adapted for multisubstrate specificity. Trends Pharmacol Sci 1990, 11, 321-324.10.1016/0165-6147(90)90235-ZSearch in Google Scholar